Teamwork takedown: GPs and pharmacists join forces to curb risky pill use in seniors

NCT ID NCT05765656

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether having a general practitioner and pharmacist work together can help people aged 65 and older safely stop or reduce benzodiazepines (drugs for sleep or anxiety). These medications raise the risk of falls, confusion, and dementia in older adults. The trial will enroll 400 patients and use motivational interviews with pharmacists to support gradual dose reduction.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
behavioral intervention (GP-pharmacist collaboration and motivational interviewing)
What this could lead to
If successful, this could provide a practical, team-based approach to safely reduce benzodiazepine use in older adults, potentially lowering risks of falls, confusion, and dementia.
What could go wrong
This is a small, early-stage trial focused on feasibility and acceptance, not on health outcomes. The intervention may not change prescribing habits or patient behavior in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nantes

    RECRUITING

    Nantes, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.